
Please try another search
For the three months ended 31 March 2022, Chandra Asri Petrochemical Tbk PT revenues increased 13% to $677.7M. Net loss totaled $11.2M vs. income of $84.4M. Revenues reflect Olefin segment increase of 55% to $111.2M, Polyolefin segment increase of 10% to $438M. Net loss reflects Labor & Related Expenses in G&A increase of 64% to $8.4M (expense), Gains (losses) on foreign exchange - net decrease from $2.3M (income) to $242K (expense).
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Total Revenue | 677.75 | 699.23 | 619.33 | 663.46 |
Gross Profit | 25.03 | 38.23 | 33.6 | 125.6 |
Operating Income | -2.75 | 17.16 | 11.1 | 103.33 |
Net Income | -11.23 | -13.28 | 1.02 | 80 |
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Total Assets | 4968.42 | 4993.06 | 4591.45 | 3513.57 |
Total Liabilities | 2056.16 | 2068.89 | 1661.05 | 1651.24 |
Total Equity | 2912.25 | 2924.17 | 2930.41 | 1862.33 |
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Period Length: | 3 Months | 12 Months | 9 Months | 6 Months |
Cash From Operating Activities | -562.57 | 221.85 | -69.91 | -130.8 |
Cash From Investing Activities | -155.33 | -695.83 | -160.31 | -17.49 |
Cash From Financing Activities | 421.11 | 1134.19 | 998.41 | -8.59 |
Net Change in Cash | -296.79 | 660.21 | 768.19 | -156.88 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review